BE785812A - Nouveaux composes steroides - Google Patents

Nouveaux composes steroides

Info

Publication number
BE785812A
BE785812A BE785812DA BE785812A BE 785812 A BE785812 A BE 785812A BE 785812D A BE785812D A BE 785812DA BE 785812 A BE785812 A BE 785812A
Authority
BE
Belgium
Prior art keywords
steroid compounds
new steroid
new
compounds
steroid
Prior art date
Application number
Other languages
English (en)
French (fr)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE785812A publication Critical patent/BE785812A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE785812D 1971-07-05 Nouveaux composes steroides BE785812A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3134971A GB1391443A (en) 1971-07-05 1971-07-05 Ester of betamethasone and its 9alpha-chloro analogue

Publications (1)

Publication Number Publication Date
BE785812A true BE785812A (fr) 1973-01-04

Family

ID=10321802

Family Applications (1)

Application Number Title Priority Date Filing Date
BE785812D BE785812A (fr) 1971-07-05 Nouveaux composes steroides

Country Status (17)

Country Link
JP (1) JPS5644079B1 (xx)
AR (2) AR194120A1 (xx)
AU (1) AU464251B2 (xx)
BE (1) BE785812A (xx)
CA (1) CA983919A (xx)
CH (1) CH609065A5 (xx)
DE (1) DE2232827A1 (xx)
DK (1) DK131474B (xx)
FR (1) FR2144761B1 (xx)
GB (1) GB1391443A (xx)
IE (1) IE36529B1 (xx)
IL (1) IL39821A (xx)
NL (1) NL169882C (xx)
NO (1) NO137754C (xx)
PH (1) PH13195A (xx)
SE (1) SE385904B (xx)
ZA (1) ZA724598B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5024427A (xx) * 1973-01-03 1975-03-15
DE2512915A1 (de) * 1974-03-27 1975-10-09 Plurichemie Anstalt 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung
JPS6163976U (xx) * 1984-10-01 1986-05-01
US8207151B2 (en) 2008-05-28 2012-06-26 Validus Biopharma Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
SE385904B (sv) 1976-07-26
CH609065A5 (en) 1979-02-15
IL39821A (en) 1976-02-29
AU464251B2 (en) 1975-08-21
AR194120A1 (es) 1973-06-22
NL169882C (nl) 1982-09-01
AU4420572A (en) 1974-01-10
NO137754C (no) 1978-04-19
DE2232827A1 (de) 1973-01-18
NO137754B (no) 1978-01-09
IL39821A0 (en) 1972-09-28
DK131474B (da) 1975-07-21
IE36529L (en) 1973-01-05
NL7209345A (xx) 1973-01-09
IE36529B1 (en) 1976-11-24
FR2144761A1 (xx) 1973-02-16
ZA724598B (en) 1973-03-28
PH13195A (en) 1980-01-18
NL169882B (nl) 1982-04-01
GB1391443A (en) 1975-04-23
CA983919A (en) 1976-02-17
JPS5644079B1 (xx) 1981-10-16
FR2144761B1 (xx) 1976-03-05
AR194553A1 (es) 1973-07-23
DK131474C (xx) 1975-12-08

Similar Documents

Publication Publication Date Title
BE775358R (fr) Composes
BE789822A (fr) Nouveaux composes heterocycliques
BE770936A (fr) Composes alcoxydinitroanilines
BE765558A (fr) Composes fluoroalkylsulfonamidoaryliques
BE787444A (fr) Composes polycycliques
BE820304A (fr) Nouveaux steroides
BE816457A (fr) Nouveaux haptenes steroides
BE789818A (fr) Composes de polycetal
BE789551A (fr) Nouveaux composes organometalliques
BE791186A (fr) Composes tricycliques
BE785657A (fr) Nouveaux composes aromatiques
BE775152A (fr) Nouveaux composes odoriferants
BE793493A (fr) Composes tricycliques
BE785812A (fr) Nouveaux composes steroides
BE761347A (fr) Nouveaux composes odoriferants
BE789459A (fr) Composes anthraquinoniques
BE791185A (fr) Composes tricycliques
BE780446A (fr) Nouveaux bis-anhydrides
BE765354A (fr) Nouveaux composes odoriferants
BE780078A (fr) Nouveaux organosilanes
BE774818A (fr) Nouveaux composes odoriferants
FI56690B (fi) Foerfarande foer framstaellning av foerestringsprodukter genom sampolymerisation
FI53921C (fi) Foerfarande foer granulering av tablettmassor i pulverform
BE778173A (fr) Nouveaux composes odoriferants
BE775618A (fr) Nouveaux composes anesthesiques

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GLAXO LABORATORIES LTD

Effective date: 19870731